Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.
about
Lipid-lowering efficacy of atorvastatinLipid lowering efficacy of atorvastatinFenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.Pharmacological management of diabetic dyslipidemia.
P2860
Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@en
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@nl
type
label
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@en
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@nl
prefLabel
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@en
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@nl
P2093
P2860
P1476
Effects of atorvastatin 10 mg ...... n-label, parallel-group study.
@en
P2093
Christophe Corda
Jean-Claude Ansquer
Karine Le Malicot
Valerie Jessent
P2860
P356
10.1016/J.CURTHERES.2009.03.002
P577
2009-04-01T00:00:00Z